Skip to main content
Figure 2 | BMC Psychiatry

Figure 2

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Figure 2

MADRS scores over time, completers (n = 42). The fitted mean and 95% confidence intervals were estimated using a repeated measures analysis of covariance (ANCOVA). The fitted model included terms for time, gender age group and history of anxiety as factors, with the baseline Montgomery-Asberg Depression Rating Scale (MADRS) score and baseline body mass index (BMI) fitted as covariates.

Back to article page